1、 Business Overview

Shanghai Hanhong currently has a synthetic biology technology platform, a chiral chemistry technology platform, and a green synthesis technology platform. It has a research and development center of 3000 square meters and 40 R&D personnel in Shanghai, and a research and development laboratory of 1000 square meters and 25 R&D personnel in Lanzhou. With its current R&D capabilities, Hanhong can provide global customers with process development and achievement transformation of active pharmaceutical ingredients and intermediates‘

2、 Organizational structure of API Research Department

The API Research Department consists of a Synthesis Research Office, a Quality Research Office, a Research and Development QA Office, a Registration and Application Office, and an Intellectual Property Office.

3、 Main business

Process R&D services: synthesis route design and screening, process optimization and scaling up, impurity formulation and confirmation, process validation, crystal structure research, etc.

Research on the Quality of Active Pharmaceutical Ingredients: Research on the quality of starting materials, intermediates, and active pharmaceutical ingredients, including the development and validation of analytical methods for organic impurities, genotoxic impurities, residual solvents, heavy metal impurities, and product stability studies.

Registration and declaration service: According to the requirements of drug registration, write registration materials, and carry out related declaration of active pharmaceutical ingredients.

4、 Main research equipment

The research department is equipped with liquid and gas phases LC-MS、 Prepare research equipment such as chromatography and IR.

5、 Research on the variety of active pharmaceutical ingredients in progress

Dulutwei

Ezetimibe

DULOXETINE

Saxagliptin

clopidogrel

Naimatwei

Perindopril

Benazepril